Premarket Gainers as of 9:05 am (02/15/2018)

|By:, SA News Editor

MBRX +48% on major breakthrough to develop a new cancer treatment.

ARGS +22% on issuance of U.S. patent covering the strain-independent amplification of human immunodeficiency virus.

AMAG +19% as FDA grants AMAG Pharma's Makena subcutaneous auto-injector.

SEDG +17% on Q4 result.

TRIP +15% on Q4 result.

ATRS +14% as FDA grants AMAG Pharma's Makena subcutaneous auto-injector.

SHLM +10% on being acquired by LyondellBasell (NYSE:LYB).

TEVA +9% on Berkshire investment.

OMER +8% as OMS721 shows treatment effect in mid-stage HCT-TMA study.

AVP +8% on Q4 result.

CTL +8% on Q4 result.

MARA +8% on expanding cryptocurrency mining operations.

YNDX +7% on Q4 result.

CSCO +7% on Q2 result.

CARA +7%.

RIOT +6% on entering into a definitive agreement to acquire additional cryptocurrency mining equipment.

OSTK +5%.

DPW +5%.